Product Information
KLOR-CON M15 TABLET is a brand (anda) product labeled by Upsher-Smith Laboratories LLC, priced at $0.4960 per EA under NDC 00245531811. Its NADAC has been published 156 times since Jul 10, 2019.
FDA first approved this application on Nov 20, 1998. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1125 mg/1
Manufacturer
Upsher-Smith Laboratories LLCNDC
00245531811
Classification
Brand (ANDA)
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074726FDA Approved
11/20/1998
TE Code
AB1
On Market Since
1/18/2011
Pharmacological Classes
Price Statistics
The NADAC for KLOR-CON M15 TABLET has been published 156 times since Jul 10, 2019, and over the history we have for it it has declined 39.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4960 per EA |
|---|---|
| All-time high | $0.8161 (Dec 11, 2019) |
| All-time low | $0.3498 (Dec 18, 2024) |
| 52-week high | $0.4960 |
| 52-week low | $0.3509 |
| Median price | $0.3882 |
| Average price | $0.4573 |
| Largest weekly change | -55.9% (Mar 20, 2024) |
| Weeks tracked | 156 |
| Tracking since | Jul 10, 2019 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Upsher-Smith Laboratories LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
potassium chloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Osmotic Laxative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KLOR-CON M15 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for KLOR-CON M15 TABLET, manufactured by Upsher-Smith Laboratories LLC, is $0.4960 per EA (NDC 00245531811), effective Sep 30, 2026.
How has the price of KLOR-CON M15 TABLET changed over time?
Over the history we have for it, the NADAC for KLOR-CON M15 TABLET has declined 39.2%. It has been tracked across 156 weekly CMS publications since Jul 10, 2019.
What are the highest and lowest recorded NADAC prices for KLOR-CON M15 TABLET?
Since Jul 10, 2019, the NADAC for KLOR-CON M15 TABLET has ranged from a low of $0.3498 (Dec 18, 2024) to a high of $0.8161 (Dec 11, 2019), with a median of $0.3882 per EA.
Are there cheaper alternatives to KLOR-CON M15 TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as KLOR-CON M15 TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures KLOR-CON M15 TABLET?
KLOR-CON M15 TABLET (NDC 00245531811) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a brand (anda) product.